Billionaire investment legend Stanley Druckenmiller is quickly becoming one of my favorite big-money managers to follow ...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you ...

Teva pharmaceuticals has issued a voluntary recall of one lot of its reflux medication after discovering that bottles contained tablets of a drug used to treat fluid retention. The recall affects lot ...

Despite the popularity of generic and biosimilar drugs in Europe—the latter of which have struggled to catch on in the ...

Two and a half years into his tenure as Teva’s CEO, Richard Francis is breaking down the strategy that’s powered the company ...

We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra Investments’ Substack by Kontra. In this ...

T eva Pharmaceutical has reported the final analysis of the PEARL Phase IV migraine prevention trial of the anti-calcitonin ...

Digital inhalers may help predict the occurrence of acute exacerbations of chronic obstructive pulmonary disease (COPD) for ...

Today, Teva Pharmaceutical Industries (TASE: TEVA; NYSE: TEVA) announced the launch of a technological innovation program in drug development, at an investment expected to reach tens of millions of ...

Check out our TEVA stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.

Final results from the Phase IV PEARL trial show that 66% of patients treated with Ajovy for episodic migraine and more than ...